{"id":"W2160643831","doi":"10.1016/s0140-6736(08)61242-8","title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":994,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Boehringer Ingelheim","keywords":"Telmisartan; Medicine; Placebo; Stroke (engine); Hazard ratio; Internal medicine; Myocardial infarction; Diabetes mellitus; Heart failure; Blood pressure; Angiotensin receptor; Randomized controlled trial; Cardiology; Angiotensin II; Confidence interval; Endocrinology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}